DR.REDDY'S LABORATORIES LTD. - 500124 - Intimation
Intimation regarding completion of transaction for sale of our wholly owned subsidiary Dr. Reddy''s Research and Development B. V. (DRRDBV)''s certain assets and liabilities including transfer of employees at site situated at Zernikedreef 12, 2333, CL Leiden, The Netherlands.
Buy Dr. Reddy's Laboratories; target of Rs 5460: Sharekhan
Sharekhan is bullish on Dr. Reddy's Laboratories has recommended buy rating on the stock with a target price of Rs 5460 in its research report dated December 21, 2022. Pharma industry needs govt's research-push to scale innovation challenges: Satish Reddy
The Chairman of Dr Reddy's Laboratories has said the current approval process for biotech products needs an overhaul DR.REDDY'S LABORATORIES LTD. - 500124 - Announcement under Regulation 30 (LODR)-Press Release / Media Release
Press Release titled ''Dr. Reddy's successfully completes Phase 1 study of DRL_TC, a proposed biosimilar of tocilizumab'' DR.REDDY'S LABORATORIES LTD. - 500124 - Intimation
Dr. Reddy''s Research and Development B. V., a wholly owned subsidiary of the Company, has entered into an Asset Purchase Agreement for sale of its certain assets and liabilities including transfer of employees at site situated at Leiden, The Netherlands. Dr Reddy's arm haltsdevelopment of oral drug forpsoriasis
Aurigene stops the oral drug clinical development with not meeting the desirable patient benefit with moderate to severepsoriasis DR.REDDY'S LABORATORIES LTD. - 500124 - Announcement under Regulation 30 (LODR)-Allotment of ESOP / ESPS
Allotment of Equity Shares on exercise of Stock Options under ESOPs DR.REDDY'S LABORATORIES LTD. - 500124 - Announcement under Regulation 30 (LODR)-Press Release / Media Release
Aurigene Oncology Limited, a wholly owned subsidiary of Dr. Reddy''s Laboratories Limited, reports results of AUR101 in Phase II Study in Patients with moderate to severe psoriasis DR.REDDY'S LABORATORIES LTD. - 500124 - Compliances-Reg. 39 (3) - Details of Loss of Certificate / Duplicate Certificate
Issue of Letter of Confirmation/Share certificate(s) in lieu of share certificate(s) reported lost/misplaced DR.REDDY'S LABORATORIES LTD. - 500124 - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation
Intimation about group investor meeting